Navocaftor (Synonyms: GLPG 3067; ABBV-3067) |
| Catalog No.GC63479 |
Navocaftor (GLPG 3067), en tant que régulateur transmembranaire de la mucoviscidose (CFTR), est un modulateur de protéines (US 20200377491 Al, exemple 1).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2159103-66-7
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Navocaftor, as a cystic fibrosis transmembrane regulator (CFTR), is a protein modulator (US 20200377491 Al, example 1)[1].
Navocaftor, as a cystic fibrosis transmembrane regulator (CFTR), is a protein modulator[1].
[1]. US 20200377491 Al
Average Rating: 5 (Based on Reviews and 24 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *